New Cardiff facility to manufacture organoids for drug discovery
Drug Discovery World
JUNE 10, 2024
A new facility has opened in Cardiff, UK designed to manufacture patient-derived organoids (PDOs) at scale for use in drug discovery and development. The multi-million-pound facility was custom-built by Molecular Devices to house its bioprocess workflow and bioreactor technology Mary Duseau, President of Molecular Devices said: “With our new facility, we now have the capacity to manufacture 300 million PDOs annually.
Let's personalize your content